New Born Screening utilizes the patented “All-in-one” multiplex PCR amplicon library preparation technology and NGS technology. It performs sequencing of all exonic regions for 130 genes associated with metabolic and genetic diseases. The test is indicated for newborns and children. Offers early screening for genetic diseases that appear during the first stages of life, providing key information for preventive management, diet for early treatment. Early detection, intervention & management could prove essential for the infant’s overall health and quality of life.
